// App-Quantinova.ai

1265 : Vedolizumab plus anti-PD1 antibody in advanced melanoma patients with inflammatory enterocolitis

Researchers

Presenter

  • Asad Javed

Principal Investigators

  • Michele Freesmeier

  • Yousef Zakharia

  • Mohammed Milhem

Medical Centers

  • University of Iowa, Iowa City, IA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

  • Oncology (ONC)

  • Gastroenterology (GU)

Disease

  • Enterocolitis

  • Melanoma

Biomarkers

  • N/A

Drug/Treatment

  • Pembrolizumab

  • Entyvio

  • Nivolumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved